Status:
NOT_YET_RECRUITING
Feasibility of Using NeuraSignal Transcranial Doppler Robot
Lead Sponsor:
University of Alabama at Birmingham
Conditions:
Cerebral Autoregulation
Eligibility:
All Genders
18-89 years
Brief Summary
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood press...
Detailed Description
This study aims to explore the feasibility of using the NeuraSignal transcranial doppler robot to generate cerebral autoregulation curves in adult patients admitted to the neuro ICU with a newly diagn...
Eligibility Criteria
Inclusion
- 18-89
- Patients admitted to the Neuro ICU for blood pressure management (MAP management) after spinal surgery
Exclusion
- Patients under 18 years (or bodyweight \<50kg if age unknown),
- prisoners
- pregnant women,
- non-English speaking,
- patients enrolled in concurrent
- ongoing interventional trial
- students of UAB
- employees of UAB
- targeting specific populations
- patients with previously diagnosed brain pathology
- patients with open wounds over temporal bones precluding transcranial doppler
Key Trial Info
Start Date :
February 15 2026
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06565442
Start Date
February 15 2026
End Date
December 15 2027
Last Update
December 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UAB Department of Anesthesiology and Perioperative Medicine
Birmingham, Alabama, United States, 35249